See other companies on Welcome to the Jungle
Ada Health
Symptoms diagnosis and treatment advisory platform
- 201-500 employees
- Healthcare
- B2B
- Personal health
- Artificial Intelligence
- SaaS
- Mitte, Berlin, Germany
Jump to section
Company mission
Improve human health by transforming knowledge into better outcomes.
Our take
The global digital health market is expected to reach $221 Billion by 2026. With more than 12 million users globally, over 26.5m assessments and a suite of AI-driven enterprise solutions, Ada is is a large player in this emerging market.
The startup’s broad global reach and deep relationships with healthcare providers and professionals has allowed it to build a market-leading symptoms-diagnosis product based on Artificial Intelligence.
The product means Ada can move beyond symptom checking to help people monitor their health continuously and take proactive steps to keep it in tip-top condition. In 2023, it partnered with Pfizer to create a COVID-19 digital care journey for sufferers of the virus. That partnership, and many of Ada's other ventures mean new B2B revenue-driving opportunities from health systems, insurers and life sciences organisations.
The idea of proactive healthcare, catching a £100k per year problem when it is a £100 problem, has been a prize that digital health companies have long sought and failed. Ada's suite of products and connections is looking to buck that trend.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Flexible working hours and locations. You can work from home, office, or a bit of both, and you’ll receive financial support to help set up a home office space.
- Country-specific vacation allowance and 1 month's unpaid leave
- Fitness membership discounts and bike leasing scheme.
- Full Headspace subscription
- Enjoy team celebrations, coffee breaks, community days, and well-stocked fridges for more impromptu gatherings
- Continue to grow with training, mentorship programs, interdisciplinary collaboration, conferences, and free language lessons
Company values
- Integrity: Do the right thing
- Quality: Raise the bar
- Humility: Seek to learn
- Purpose: Make a difference
- Collaboration: Succeed as a team
- Innovation: Build the future
Funding (last 2 of 5 rounds)
Feb 2022
$30m
SERIES B
May 2021
$90m
SERIES B
Total funding: $184.7m
Leadership
Claire Novorol
(Chief Medical Officer)Before founding Ada, Claire worked as a Paediatrician in London before specialising in Clinical Genetics. She has degrees in Pathology and Medicine as well as a PhD in Neuroscience from the University of Cambridge.
Daniel Nathrath
(CEO)Founded and led several internet startups based in Denmark, Germany, the US, and the UK. Earned an MBA from University of Chicago before working as a consultant for BCG.
Prof. Dr. Martin Hirsch
(Chief Scientific Advisor)Published work on nerve modeling in Nature before starting a company around a nerve modeling program that saved thousands of animals from lab testing. Martin has a PhD in neuroscience and a diploma in physiology.